Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 2, 2014
Pharmacy Choice - News - Front Page Healthcare News - October 2, 2014

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/2/14 - Ad Watch: Republicans rehash misleading claims on Ami Bera [The Sacramento Bee]
Ami Bera, D- Elk Grove, seeks to paint the freshman lawmaker and medical doctor as a free-spending hyper-partisan who would cut entitlements. Text: Ami Bera talks about putting people first. Bera even supported Obamacare, which cuts Medicare by $700 billion, and cuts Medicare Advantage by $900 billion for local seniors.
10/2/14 - Ad Watch: Republicans rehashes misleading claims on Ami Bera [The Sacramento Bee]
Ami Bera, D- Elk Grove, seeks to paint the freshman lawmaker and medical doctor as a free-spending hyper-partisan who would cut entitlements. Text: Ami Bera talks about putting people first. Bera even supported Obamacare, which cuts Medicare by $700 billion, and cuts Medicare Advantage by $900 billion for local seniors.
10/2/14 - Biofrontera Gets Positive Results From Ameluz US Clinical Trials
LONDON- Biofrontera AG Thursday said it has completed the clinical programme for US approval of its Ameluz product, with trials confirming the efficacy and safety of the treatment. In addition, only 38% of the patients required the second treatment, Biofrontera said. Along with the phase 3 trial, Biofrontera said the US Food and Drug Administration
10/2/14 - Content of Premarket Submissions for Management of Cybersecurity in Medical Devices; Guidance for Industry and Food and Drug Administration Staff;...
Content of Premarket Submissions for Management of Cybersecurity in Medical Devices; Guidance for Industry and Food and Drug Administration Staff; Availability. Submit written requests for single copies of the guidance document entitled "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices" to the Office of the Center
10/2/14 - FDA Clears NEMARIS' Next-Generation SURGIMAP 2.0 Software for Personalized Spinal Implants [Professional Services Close - Up]
SURGIMAP 2.0 includes the UNiD plug in, jointly developed with one of the company's strategic partners, MEDICREA,, a company that specializes in the development of surgical technologies for the treatment of spinal pathologies. The UNiD plug in is embedded into the SURGIMAP 2.0 software interface, and provides surgeons an option for planning and ord
10/2/14 - Health care advocate set to retire [Charleston Daily Mail, W.Va.]
Oct. 02 Consumers should have a voice in their health care and thanks to Perry Bryant residents of West Virginia have the opportunity to have a seat at the table. Perry, executive director of West Virginians for Affordable Health Care, is set to retire at the end of the year. Bryant worked for the West Virginia Education Association for about
10/2/14 - Israel Healthcare, Regulatory and Reimbursement Landscape 2014-2020 - Market Outlook for the $2.3 Billion Industry
Dublin- Research and Markets has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape- Israel" report to their offering. Israel is one of the major markets in terms of healthcare and pharmaceuticals in the Middle East. According to the US Patent and Trademark Office, Israel has the highest number of regist
10/2/14 - Post hoc health care economics [LifeHealthPro]
Fred sneezes at the exact same time as the earthquake occurs; therefore Fred's sneeze caused the earthquake. That is an example of a completely implausible post hoc argument. Drew Altman, chief executive of the Kaiser Family Foundation said, "We're in a period of historic moderation in premium costs.
10/2/14 - Rauner, Quinn clash on Obamacare expansion ahead of president's Chicago visit [Chicago Tribune]
Oct. 01 Republican governor candidate Bruce Rauner acknowledged Wednesday he would have vetoed legislation expanding government-subsidized Medicaid to low-income people under President Barack Obama's signature health care law, but does not support a rollback in coverage. Quinn has said the federal government-paid expansion added 468,000 people to
10/2/14 - Research and Markets Adds Report: FDA Approval Process for Medical Devices - Highlighting the new changes in medical device regulations and providing... [Manufacturing Close - Up]
Research and Markets Adds Report: FDA Approval Process for Medical Devices- Highlighting the new changes in medical device regulations and providing an overview for FDA submissions. Research and Markets has announced the addition of the "FDA Approval Process for Medical Devices- Highlighting the new changes in medical device regulations and providi
10/2/14 - Research and Markets Adds Report: FDA Approval Process for Medical Devices - Highlighting the New Changes in Medical Device Regulations and Providing... [Professional Services Close - Up]
Research and Markets Adds Report: FDA Approval Process for Medical Devices- Highlighting the New Changes in Medical Device Regulations and Providing an Overview for FDA submissions. Research and Markets has announced the addition of the "FDA Approval Process for Medical Devices- Highlighting the new changes in medical device regulations and providi
10/2/14 - Research and Markets Adds Report: FDA Approval Process for Medical Devices and FDA Quality System Management for Medical Devices [Manufacturing Close - Up]
This seminar will highlight new changes in the medical device regulations and provide an overview of the submission of documents to the FDA for approval of medical device products. Information on maintaining ongoing relationships with the FDA will also be discussed. This course provides a comprehensive introduction to FDA's Medical Device Good...
10/2/14 - Research and Markets Adds Report: FDA Approval Process for Medical Devices and FDA Quality System Management for Medical Devices [Professional Services Close - Up]
This seminar will highlight new changes in the medical device regulations and provide an overview of the submission of documents to the FDA for approval of medical device products. Information on maintaining ongoing relationships with the FDA will also be discussed. This course provides a comprehensive introduction to FDA's Medical Device Good...
10/2/14 - Research and Markets Adds Report: FDA Quality System Management for Medical Devices - A comprehensive introduction to the FDAs Medical Device Good... [Manufacturing Close - Up]
This course provides a comprehensive introduction to FDA's Medical Device Good Manufacturing Practices regulation. Delegates will hear FDA's interpretation of all the subparts of the QSR and how FDA will inspect manufacturing facilities under this regulation. In addition, participants will gain knowledge about FDA's Field Force, FDA's compliance...
10/2/14 - Research and Markets Adds Report: FDA Quality System Management for Medical Devices - A Comprehensive Introduction to the FDAs Medical Device Good... [Professional Services Close - Up]
This course provides a comprehensive introduction to FDA's Medical Device Good Manufacturing Practices regulation. Delegates will hear FDA's interpretation of all the subparts of the QSR and how FDA will inspect manufacturing facilities under this regulation. In addition, participants will gain knowledge about FDA's Field Force, FDA's compliance...
10/2/14 - Salix Pharmaceuticals and Progenics Pharmaceuticals Secure FDA Approval of RELISTOR Subcutaneous Injection [Professional Services Close - Up]
Salix Pharmaceuticals and Progenics Pharmaceuticals, Inc. announced that the Food and Drug Administration has approved RELISTOR Subcutaneous Injection, 12 mg/ 0.6 ml, for the treatment of opioid-induced constipation in patients taking opioids for chronic non-cancer pain. According to a media release, RELISTOR subcutaneous injection is available...
10/2/14 - United Kingdom : Hikma receives approval for colchicine 0.6mg capsules [TendersInfo (India)]
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today announces the approval of its New Drug Application for colchicine 0.6 mg capsules by the US Food and Drug Administration. Hikma will market its colchicine under the brand name MITIGARE. Said Darwazah, Chairman and CEO of Hikma, said, "This approval demonstrates ou
10/1/14 - Aerocrine and Microsoft collaborate to test secure, cloud-based remote medical device monitoring [Global Data Point]
The collaboration will utilize Microsoft's secure cloud services to transmit device telemetry data from physician and company sites in Sweden, UK and US back to Aerocrine for analyses. Aerocrine's goal is to use this information to deploy its field resources for customer service and sales support in the future. Microsoft chose Aerocrine due to its
10/1/14 - Aetna Introduces New, Zero-Plan Premium Medicare Advantage Offering with Northern New Jersey Health Systems
The health systems Atlantic Health System, Hackensack University Health Network and Hunterdon Healthcare as well as the providers affiliated with each of them, will coordinate to provide high quality, efficient, convenient and affordable care to New Jersey Medicare beneficiaries. When we set out to build this plan, we wanted to offer care fr
10/1/14 - Aetna, Hill Physicians Medical Group and Dignity Health's Hospitals and Medical Foundation Form Accountable Care Collaboration in Northern California
Aetna, Hill Physicians Medical Group, Inc., Dignity Health Medical Foundation and Dignity Health hospitals today announced an accountable care collaboration and the introduction of the Aetna Whole Health SM product. This new collaboration with Hill Physicians Inc. and Dignity Health will provide coordinated care for Aetna members through more than
10/1/14 - AMN Healthcare to Host 2014 Third Quarter Earnings Conference Call on Thursday, October 30, 2014
A live webcast of the call can be accessed through AMN Healthcare's website at http://amnhealthcare.investorroom.com/presentations. AMN Healthcare is the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare's workforce solutions- including managed services programs, vendor...
10/1/14 - Auxilium Responds To Unsolicited Proposal From Endo International
By a News Reporter-Staff News Editor at Biotech Week Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, confirmed that Auxilium has received an unsolicited, non-binding proposal from Endo International plc to acquire all of the outstanding shares of Auxilium common stock at a price of $28.10 per share in cash and Endo stock, s
10/1/14 - Avalanche Biotechnologies to Participate in Gene Therapy Panel at the BIO Investor Forum
Avalanche Biotechnologies, Inc., a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases, today announced that Thomas W. Chalberg, Jr., Ph.D., Founder and Chief Executive Officer, will participate in the "Gene Therapy Ascending?
10/1/14 - CELEXION Granted Three U.S. Patents for Renewable Chemical Manufacturing
Celexion, a bioengineering company developing powerful platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and life science research sectors, today announced that the United States Patent and Trademark Office has recently granted three U.S. patents to the company, bringing the total U.S. patents issued
10/1/14 - Comply with Weighing-Related Regulations in Pharma Manufacturing
Greifensee, Switzerland October 01, 2014. Weighing applications in pharmaceutical manufacturing can strongly influence the quality of the final product. METTLER TOLEDO experts have created a new white paper, " Regulatory Compliance Weighing in Pharma Manufacturing" that provides a comprehensive overview of weighing-related standards and regulati
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415